1 results match your criteria: "Breslin Cancer Center 401[Affiliation]"
Salivary gland cancers: current treatments, molecular characteristics and new therapies.
Expert Rev Anticancer Ther
April 2008
Division of Hematology/Oncology, Michigan State University, Breslin Cancer Center 401, W. Greenlawn Avenue, Lansing, MI, USA.
Salivary gland cancers are relatively rare and quite diverse. Current therapy relies on local ablation. There are few large clinical trials or randomized trials to guide treatment, especially for metastatic disease.
View Article and Find Full Text PDF